November 2022

News

November 30, 2022

NIH Wins Licensing Executive Society Deals of Distinction Award for WHO C-TAP Partnership | Technology Transfer

The NIH Technology Transfer Program has won the Licensing Executive Society’s Deals of Distinction award…

Super User 0

Love0

BHI Weekly News Archives

November 29, 2022

535th Edition, November 29, 2022

Trouble Viewing This Email: Click Here November 29, 2022 FOUNDING MEMBER OF Montgomery…

Super User 0

Love0

News

November 29, 2022

Montgomery County and BioHealth Innovation, Inc. welcome Luis Gutierrez as an “Executive in Residence” to Help Grow County’s Biotech Industry (Updated 11/29)

Updated 11/29 BioHealth Innovation, Inc. (BHI) and Montgomery County are pleased to announce the selection…

Super User 0

Love0

2022 BioBuzz 3rd Award LinkedIn 1200 x 627

News

November 28, 2022

Announcing Your 3rd Annual BioBuzz Awards Finalists · BioBuzz

We’re excited to announce this year’s finalists for the third annual 2022 BioBuzz Awards. These awards…

Super User 0

Love0

News

November 28, 2022

Johns Hopkins Researchers Design ‘Prodrug’ That Targets Cancer Cells’ Big Appetite for Glutamine, Leaving Healthy Cells Unharmed

Johns Hopkins Medicine researchers have revamped an anti-cancer drug to better target cancer cells and…

Super User 0

Love0

News

November 28, 2022

Haystack Oncology Inks Lease In Baltimore’s City Garage

Biotechnology firm Haystack Oncology Inc. has signed a lease in the City Garage Science & Technology Center at the recently…

Super User 0

Love0

News

November 28, 2022

QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance | Business Wire

HILDEN, Germany & GERMANTOWN, Maryland--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced…

Super User 0

Love0

BHI Weekly News Archives

November 22, 2022

534th Edition, November 22, 2022

Trouble Viewing This Email: Click Here November 22, 2022 FOUNDING MEMBER OF MacroGenics…

Super User 0

Love0

News

November 21, 2022

MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab

ROCKVILLE, MD, Nov. 17, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing…

Super User 0

Love0

News

November 21, 2022

On the Road Montgomery County: Biotech boom not happening everwhere – Washington Business Journal

In Montgomery County, lab space has long been a prized get for biotechs, because there was…

Super User 0

Love0

NIH Wins Licensing Executive Society Deals of Distinction Award for WHO C-TAP Partnership | Technology Transfer

535th Edition, November 29, 2022

Montgomery County and BioHealth Innovation, Inc. welcome Luis Gutierrez as an “Executive in Residence” to Help Grow County’s Biotech Industry (Updated 11/29)

Announcing Your 3rd Annual BioBuzz Awards Finalists · BioBuzz

Johns Hopkins Researchers Design ‘Prodrug’ That Targets Cancer Cells’ Big Appetite for Glutamine, Leaving Healthy Cells Unharmed

Haystack Oncology Inks Lease In Baltimore’s City Garage

QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance | Business Wire

534th Edition, November 22, 2022

MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab

On the Road Montgomery County: Biotech boom not happening everwhere – Washington Business Journal

About BioHealth Innovation

Contact

Connect